Perrigo Company PLC
NYSE:PRGO
Perrigo Company PLC
EPS (Diluted)
Perrigo Company PLC
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Perrigo Company PLC
NYSE:PRGO
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
EPS (Diluted)
$8
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
27%
|
|
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
EPS (Diluted)
$0
|
CAGR 3-Years
52%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
EPS (Diluted)
$0
|
CAGR 3-Years
27%
|
CAGR 5-Years
11%
|
CAGR 10-Years
15%
|
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
EPS (Diluted)
$0
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-137%
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
EPS (Diluted)
€8
|
CAGR 3-Years
85%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
Perrigo Company PLC
Glance View
Perrigo Company PLC, a stalwart in the pharmaceutical and healthcare sectors, has carved a niche by specializing in over-the-counter (OTC) health and wellness products. This Dublin-based company traces its origins back to 1887, in Allegan, Michigan, where it began as a modest packager of home remedies. Over the decades, Perrigo has evolved into a global powerhouse that provides affordable and quality healthcare products, distributing them across various markets around the world. Its strategy hinges on delivering effective OTC solutions and a wide array of consumer self-care products, making it a familiar presence in households seeking reliable alternatives to more expensive brand-name pharmaceuticals. Perrigo's business model is centered on offering value to both consumers and retailers. By producing generic versions of well-known drugs, it captures a significant share of the market driven by cost-conscious customers. This approach also involves collaborating with retail giants to supply their private label OTC medications, a mutually beneficial arrangement that allows retailers to offer lower-cost alternatives under their own brands while maintaining healthy margins. Beyond just OTC medications, Perrigo has expanded its offerings to include nutritional products and topical solutions, further diversifying its portfolio and revenue streams. The company's consistent investment in innovation and keen attention to regulatory compliance underscore its commitment to quality and safety, attributes that resonate well in an industry guided by trust and efficacy.
See Also
What is Perrigo Company PLC's EPS (Diluted)?
EPS (Diluted)
-1.3
USD
Based on the financial report for Dec 31, 2024, Perrigo Company PLC's EPS (Diluted) amounts to -1.3 USD.
What is Perrigo Company PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-35%
Over the last year, the EPS (Diluted) growth was -1 289%. The average annual EPS (Diluted) growth rates for Perrigo Company PLC have been -35% over the past three years .
You don't have any saved screeners yet